Purpose
To achieve low cost of goods for monoclonal antibodies which is crucial for providing affordable solutions for prevention and treatment of infectious diseases for people in low/middle income countries.
Grantee
Division
Global Health
Date
JUNE 2025
Region served
GLOBAL
Committed amount
$742,123
Grant topic
Vaccine Development
Duration (months)
20
Grantee location
Raleigh, North Carolina, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.